Zobrazeno 1 - 10
of 341
pro vyhledávání: '"W. Ray Kim"'
Autor:
Miho Akabane, MD, Allison Kwong, MD, Yuki Imaoka, MD, PhD, Carlos O. Esquivel, MD, PhD, W. Ray Kim, MD, Marc L. Melcher, MD, PhD, Kazunari Sasaki, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 10, p e1661 (2024)
Background. The global surge in aging has intensified debates on liver transplantation (LT) for candidates aged 75 y and older, given the prevalent donor scarcity. This study examined both the survival benefits and organ utility of LT for this age gr
Externí odkaz:
https://doaj.org/article/1cdba670b2294447935687f23259d18e
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101127- (2024)
Background & Aims: The new nomenclature of steatotic liver disease (SLD) was recently launched with sub-classifications of metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (
Externí odkaz:
https://doaj.org/article/00101b1aebe14712a6e27e727a1c9685
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1657 (2024)
Background. The role of donor age in liver transplantation (LT) outcomes for hepatocellular carcinoma (HCC) is controversial. Given the significant risk of HCC recurrence post-LT, optimizing donor/recipient matching is crucial. This study reassesses
Externí odkaz:
https://doaj.org/article/290a1cb0f08f45e4b8185d5a4b594c96
Autor:
Omar Alshuwaykh, Tami Daugherty, Amanda Cheung, Aparna Goel, Renumathy Dhanasekaran, T. Tara Ghaziani, Aijaz Ahmed, Deepti Dronamraju, Radhika Kumari, Allison Kwong, Mindie Nguyen, W. Ray Kim, Paul Yien Kwo
Publikováno v:
Hepatology Communications, Vol 6, Iss 11, Pp 3052-3061 (2022)
Abstract Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular carcinoma (HCC). The aim of this study was to explore the incidence of HCC in a cohort of subjects with HBV and correlate with HBV treatment current guid
Externí odkaz:
https://doaj.org/article/3adeae4f48864b8ca84f80d8786246df
Autor:
Omar Alshuwaykh, Amanda Cheung, Aparna Goel, Allison Kwong, Renumathy Dhanasekaran, T. Tara Ghaziani, Aijaz Ahmed, Tami Daugherty, Deepti Dronamraju, Radhika Kumari, Mindie Nguyen, W. Ray Kim, Paul Yien Kwo
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Malignancy-related ascites accounts for approximately 10% of causes of ascites. Our AIM was to characterize the ascites fluid and correlate clinical outcomes in those with extrahepatic malignancy and ascites. Methods 241 subjects
Externí odkaz:
https://doaj.org/article/cdb23d956fb74330b0daaf779e844516
Autor:
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 1881-1894 (2022)
Abstract Real‐world data are limited on tenofovir alafenamide (TAF). We aimed to study TAF real‐world outcomes with other first‐line regimens for chronic hepatitis B (CHB). We enrolled patients with CHB from 10 centers retrospectively and follo
Externí odkaz:
https://doaj.org/article/c069a6f091ce4455a5cb4d4d17687cc2
Autor:
Omar Alshuwaykh, Allison Kwong, Aparna Goel, Amanda Cheung, Renumathy Dhanasekaran, Aijaz Ahmed, Tami Daugherty, Deepti Dronamraju, Radhika Kumari, W. Ray Kim, Mindie H. Nguyen, Carlos O. Esquivel, Waldo Concepcion, Marc Melcher, Andy Bonham, Thomas Pham, Amy Gallo, Paul Yien Kwo
Publikováno v:
Hepatology Communications, Vol 5, Iss 3, Pp 516-525 (2021)
Liver transplantation (LT) is definitive treatment for end‐stage liver disease. This study evaluated factors predicting successful evaluation in patients transferred for urgent inpatient LT evaluation. Eighty‐two patients with cirrhosis were tran
Externí odkaz:
https://doaj.org/article/a4ffcf5e23564c8b96be8a0bf78fc988
Autor:
Young-Suk Lim, W. Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F. Flaherty, Leland J. Yee, Lewis R. Roberts, Homie Razavi, Patrick T. F. Kennedy
Publikováno v:
Viruses, Vol 15, Iss 4, p 997 (2023)
Chronic hepatitis B (CHB) is the most common cause of hepatocellular carcinoma (HCC) worldwide. Antiviral treatment reduces the risk of HCC and mortality; nonetheless, globally in 2019, only 2.2% of CHB patients received treatment. Current internatio
Externí odkaz:
https://doaj.org/article/b0f820d04b534e6eae9f1231aec2919b
Publikováno v:
Gut and Liver, Vol 10, Iss 4, Pp 611-616 (2016)
Background/AimsDespite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore the potential efficacy of combination th
Externí odkaz:
https://doaj.org/article/d61aeab500984d88b19d74f2c1deccdd
Publikováno v:
Digestive Diseases and Sciences. 68:995-1005